Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study

Authors: Henry Jensen, Marie Louise Tørring, Frede Olesen, Jens Overgaard, Peter Vedsted

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Many countries have implemented standardised cancer patient pathways (CPPs) to ensure fast diagnosis of patients suspected of having cancer. Yet, studies are sparse on the impact of such CPPs, and few have distinguished between referral routes. For incident cancer patients, we aimed to determine how often GPs suspected cancer at the time of first presentation of symptoms in general practice and to describe the routes of referral for further investigation. In addition, we aimed to analyse if the GP’s suspicion of cancer could predict the choice of referral to a CPP. Finally, we aimed to analyse associations between not only cancer suspicion and time to cancer diagnosis, but also between choice of referral route and time to cancer diagnosis.

Methods

We conducted a population-based, cross-sectional study of incident cancer patients in Denmark who had attended general practice prior to their diagnosis of cancer. Data were collected from GP questionnaires and national registers. We estimated the patients’ chance of being referred to a CPP (prevalence ratio (PR)) using Poisson regression. Associations between the GP’s symptom interpretation, use of CPP and time to diagnosis were estimated using quantile regression.

Results

5,581 questionnaires were returned (response rate: 73.8%). A GP was involved in diagnosing the cancer in 4,101 (73.5%) cases (3,823 cases analysed). In 48.2% of these cases, the GP interpreted the patient’s symptoms as ‘alarm’ symptoms suggestive of cancer. The GP used CPPs in 1,426 (37.3%) cases. Patients, who had symptoms interpreted as ‘vague’ had a lower chance of being referred to a CPP than when interpreted as ‘alarm’ symptoms (PR = 0.53 (95%CI: 0.48;0.60)). Patients with ‘vague’ symptoms had a 34 (95% CI: 28;41) days longer median time to diagnosis than patients with ‘alarm’ symptoms.

Conclusions

GPs suspect cancer more often than they initiate a CPP, and patients were less likely to be referred to a CPP when their symptoms were not interpreted as alarm symptoms of cancer. The GP’s choice of referral route was a strong predictor of the duration of the diagnostic interval, but the GP’s symptom interpretation was approximately twice as strong an indicator of a longer diagnostic interval.
Appendix
Available only for authorised users
Literature
1.
go back to reference Prades J, Espinas JA, Font R, Argimon JM, Borras JM: Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study. Br J Cancer. 2011, 105: 753-759. 10.1038/bjc.2011.308.CrossRefPubMedPubMedCentral Prades J, Espinas JA, Font R, Argimon JM, Borras JM: Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study. Br J Cancer. 2011, 105: 753-759. 10.1038/bjc.2011.308.CrossRefPubMedPubMedCentral
2.
go back to reference Probst HB, Hussain ZB, Andersen O: Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-A national Danish project. Health Policy. 2012, 105: 65-70. 10.1016/j.healthpol.2011.11.001.CrossRefPubMed Probst HB, Hussain ZB, Andersen O: Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-A national Danish project. Health Policy. 2012, 105: 65-70. 10.1016/j.healthpol.2011.11.001.CrossRefPubMed
4.
go back to reference Toustrup K, Lambertsen K, Birke-Sorensen H, Ulhoi B, Sorensen L, Grau C: Reduction in waiting time for diagnosis and treatment of head and neck cancer - a fast track study. Acta Oncol. 2011, 50: 636-641. 10.3109/0284186X.2010.551139.CrossRefPubMed Toustrup K, Lambertsen K, Birke-Sorensen H, Ulhoi B, Sorensen L, Grau C: Reduction in waiting time for diagnosis and treatment of head and neck cancer - a fast track study. Acta Oncol. 2011, 50: 636-641. 10.3109/0284186X.2010.551139.CrossRefPubMed
5.
go back to reference Vallverdu-Cartie H, Comajuncosas-Camp J, Orbeal-Saenz RA, Lopez-Negre JL, Gris Garriga PJ, Jimeno-Fraile J, Hermoso-Bosch J, Sanchez-Pradell C, Torra-Alsina S, Urgelles-Bosch J, Pares D: Results of implementation of a fast track pathway for diagnosis of colorectal cancer. Rev Esp Enferm Dig. 2011, 103: 402-407. 10.4321/S1130-01082011000800003.CrossRefPubMed Vallverdu-Cartie H, Comajuncosas-Camp J, Orbeal-Saenz RA, Lopez-Negre JL, Gris Garriga PJ, Jimeno-Fraile J, Hermoso-Bosch J, Sanchez-Pradell C, Torra-Alsina S, Urgelles-Bosch J, Pares D: Results of implementation of a fast track pathway for diagnosis of colorectal cancer. Rev Esp Enferm Dig. 2011, 103: 402-407. 10.4321/S1130-01082011000800003.CrossRefPubMed
6.
go back to reference Valentin-Lopez B, Ferrandiz-Santos J, Blasco-Amaro JA, Morillas-Sainz JD, Ruiz-Lopez P: Assessment of a rapid referral pathway for suspected colorectal cancer in Madrid. Fam Pract. 2012, 29: 182-188. 10.1093/fampra/cmr080.CrossRefPubMed Valentin-Lopez B, Ferrandiz-Santos J, Blasco-Amaro JA, Morillas-Sainz JD, Ruiz-Lopez P: Assessment of a rapid referral pathway for suspected colorectal cancer in Madrid. Fam Pract. 2012, 29: 182-188. 10.1093/fampra/cmr080.CrossRefPubMed
7.
go back to reference Department of Health: The NHS Cancer Plan. A plan for investment, A plan for reform. 2000, London: Department of Health Department of Health: The NHS Cancer Plan. A plan for investment, A plan for reform. 2000, London: Department of Health
8.
9.
go back to reference Potter S, Govindarajulu S, Shere M, Braddon F, Curran G, Greenwood R, Sahu AK, Cawthorn SJ: Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study. BMJ. 2007, 335: 288-10.1136/bmj.39258.688553.55.CrossRefPubMedPubMedCentral Potter S, Govindarajulu S, Shere M, Braddon F, Curran G, Greenwood R, Sahu AK, Cawthorn SJ: Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study. BMJ. 2007, 335: 288-10.1136/bmj.39258.688553.55.CrossRefPubMedPubMedCentral
11.
go back to reference Neal RD, Allgar VL, Ali N, Leese B, Heywood P, Proctor G, Evans J: Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. Br J Gen Pract. 2007, 57: 212-219.PubMedPubMedCentral Neal RD, Allgar VL, Ali N, Leese B, Heywood P, Proctor G, Evans J: Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. Br J Gen Pract. 2007, 57: 212-219.PubMedPubMedCentral
12.
go back to reference Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S, Richards M: Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer. 2012, 107: 1220-1226. 10.1038/bjc.2012.408.CrossRefPubMedPubMedCentral Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S, Richards M: Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer. 2012, 107: 1220-1226. 10.1038/bjc.2012.408.CrossRefPubMedPubMedCentral
13.
go back to reference Allgar VL, Neal RD, Ali N, Leese B, Heywood P, Proctor G, Evans J: Urgent GP referrals for suspected lung, colorectal, prostate and ovarian cancer. Br J Gen Pract. 2006, 56: 355-362.PubMedPubMedCentral Allgar VL, Neal RD, Ali N, Leese B, Heywood P, Proctor G, Evans J: Urgent GP referrals for suspected lung, colorectal, prostate and ovarian cancer. Br J Gen Pract. 2006, 56: 355-362.PubMedPubMedCentral
14.
go back to reference The National Board of Health: National Cancer Plan II • Denmark National Board of Health recommendations for improving cancer healthcare services. 2005, Copenhagen: The National Board of Health The National Board of Health: National Cancer Plan II • Denmark National Board of Health recommendations for improving cancer healthcare services. 2005, Copenhagen: The National Board of Health
15.
go back to reference Svendsen RP, Stovring H, Hansen BL, Kragstrup J, Sondergaard J, Jarbol DE: Prevalence of cancer alarm symptoms: A population-based cross-sectional study. Scand J Prim Health Care. 2010, 28: 132-137. 10.3109/02813432.2010.505412.CrossRefPubMedPubMedCentral Svendsen RP, Stovring H, Hansen BL, Kragstrup J, Sondergaard J, Jarbol DE: Prevalence of cancer alarm symptoms: A population-based cross-sectional study. Scand J Prim Health Care. 2010, 28: 132-137. 10.3109/02813432.2010.505412.CrossRefPubMedPubMedCentral
16.
go back to reference Jones R, Charlton J, Latinovic R, Gulliford M: Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ. 2009, 339: 1-9. Jones R, Charlton J, Latinovic R, Gulliford M: Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ. 2009, 339: 1-9.
17.
go back to reference Jones R, Latinovic R, Charlton J, Gulliford MC: Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ. 2007, 334: 1040-10.1136/bmj.39171.637106.AE.CrossRefPubMedPubMedCentral Jones R, Latinovic R, Charlton J, Gulliford MC: Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ. 2007, 334: 1040-10.1136/bmj.39171.637106.AE.CrossRefPubMedPubMedCentral
18.
go back to reference Neal RD, Din NU, Hamilton W, Ukoumunne OC, Carter B, Stapley S, Rubin G: Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer. 2014, 110: 584-592. 10.1038/bjc.2013.791.CrossRefPubMed Neal RD, Din NU, Hamilton W, Ukoumunne OC, Carter B, Stapley S, Rubin G: Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer. 2014, 110: 584-592. 10.1038/bjc.2013.791.CrossRefPubMed
19.
go back to reference Scheel BI, Ingebrigtsen SG, Thorsen T, Holtedahl K: Cancer suspicion in general practice: the role of symptoms and patient characteristics, and their association with subsequent cancer. Br J Gen Pract. 2013, 63: 627-635.CrossRef Scheel BI, Ingebrigtsen SG, Thorsen T, Holtedahl K: Cancer suspicion in general practice: the role of symptoms and patient characteristics, and their association with subsequent cancer. Br J Gen Pract. 2013, 63: 627-635.CrossRef
20.
go back to reference Ingebrigtsen SG, Scheel BI, Hart B, Thorsen T, Holtedahl K: Frequency of ‘warning signs of cancer’ in Norwegian general practice, with prospective recording of subsequent cancer. Fam Pract. 2013, 30: 153-160. 10.1093/fampra/cms065.CrossRefPubMed Ingebrigtsen SG, Scheel BI, Hart B, Thorsen T, Holtedahl K: Frequency of ‘warning signs of cancer’ in Norwegian general practice, with prospective recording of subsequent cancer. Fam Pract. 2013, 30: 153-160. 10.1093/fampra/cms065.CrossRefPubMed
21.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. 2012, Lyon: International Agency for Research on Cancer Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. 2012, Lyon: International Agency for Research on Cancer
22.
go back to reference Andersen JS, Olivarius NF, Krasnik A: The Danish National Health Service Register. Scand J Public Health. 2011, 39: 34-37. 10.1177/1403494810394718.CrossRefPubMed Andersen JS, Olivarius NF, Krasnik A: The Danish National Health Service Register. Scand J Public Health. 2011, 39: 34-37. 10.1177/1403494810394718.CrossRefPubMed
23.
go back to reference Larsen MB, Jensen H, Hansen RP, Olesen F, Vedsted P: Identification of patients with incident cancers using administrative registry data. Dan Med J. 2014, 61: A4777-PubMed Larsen MB, Jensen H, Hansen RP, Olesen F, Vedsted P: Identification of patients with incident cancers using administrative registry data. Dan Med J. 2014, 61: A4777-PubMed
24.
go back to reference Lynge E, Sandegaard JL, Rebolj M: The Danish National Patient Register. Scand J Public Health. 2011, 39: 30-33. 10.1177/1403494811401482.CrossRefPubMed Lynge E, Sandegaard JL, Rebolj M: The Danish National Patient Register. Scand J Public Health. 2011, 39: 30-33. 10.1177/1403494811401482.CrossRefPubMed
25.
go back to reference Gjerstorff ML: The Danish Cancer Registry. Scand J Public Health. 2011, 39: 42-45. 10.1177/1403494810393562.CrossRefPubMed Gjerstorff ML: The Danish Cancer Registry. Scand J Public Health. 2011, 39: 42-45. 10.1177/1403494810393562.CrossRefPubMed
26.
go back to reference Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD: The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012, 106: 1262-1267. 10.1038/bjc.2012.68.CrossRefPubMedPubMedCentral Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD: The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012, 106: 1262-1267. 10.1038/bjc.2012.68.CrossRefPubMedPubMedCentral
27.
go back to reference The National Board of Health: Det moderniserede Cancerregister - metode og kvalitet [In Danish]. 2009, Copenhagen: The National Board of Health The National Board of Health: Det moderniserede Cancerregister - metode og kvalitet [In Danish]. 2009, Copenhagen: The National Board of Health
28.
go back to reference Pedersen CB: The Danish Civil Registration System. Scand J Public Health. 2011, 39: 22-25. 10.1177/1403494810387965.CrossRefPubMed Pedersen CB: The Danish Civil Registration System. Scand J Public Health. 2011, 39: 22-25. 10.1177/1403494810387965.CrossRefPubMed
29.
go back to reference Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V: Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011, 173: 676-682. 10.1093/aje/kwq433.CrossRefPubMed Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V: Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011, 173: 676-682. 10.1093/aje/kwq433.CrossRefPubMed
30.
go back to reference Thygesen LC, Daasnes C, Thaulow I, Bronnum-Hansen H: Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health. 2011, 39: 12-16. 10.1177/1403494811399956.CrossRefPubMed Thygesen LC, Daasnes C, Thaulow I, Bronnum-Hansen H: Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health. 2011, 39: 12-16. 10.1177/1403494811399956.CrossRefPubMed
31.
go back to reference UNESCO: International Standard Classification of Education ISCED 2011. 2012, Montreal, Quebec, Canada: UNESCO UNESCO: International Standard Classification of Education ISCED 2011. 2012, Montreal, Quebec, Canada: UNESCO
33.
go back to reference Jensen H, Torring ML, Larsen MB, Vedsted P: Existing data sources for clinical epidemiology: Danish Cancer in Primary Care (CaP) cohort. Clin Epidemiol. 2014, 6: 237-246.CrossRefPubMedPubMedCentral Jensen H, Torring ML, Larsen MB, Vedsted P: Existing data sources for clinical epidemiology: Danish Cancer in Primary Care (CaP) cohort. Clin Epidemiol. 2014, 6: 237-246.CrossRefPubMedPubMedCentral
34.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013, 49: 1374-1403. 10.1016/j.ejca.2012.12.027.CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013, 49: 1374-1403. 10.1016/j.ejca.2012.12.027.CrossRefPubMed
35.
go back to reference Barros AJ, Hirakata VN: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003, 3: 21-10.1186/1471-2288-3-21.CrossRefPubMedPubMedCentral Barros AJ, Hirakata VN: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003, 3: 21-10.1186/1471-2288-3-21.CrossRefPubMedPubMedCentral
36.
go back to reference Miranda A: QCOUNT: Stata program to fit quantile regression models for count data. 2006, Boston: Boston College Department of Economics Miranda A: QCOUNT: Stata program to fit quantile regression models for count data. 2006, Boston: Boston College Department of Economics
37.
38.
go back to reference Machado JA, Santos Silva JMC: Quantiles for Counts. J Am Stat Assoc. 2005, 100: 1225-1237.CrossRef Machado JA, Santos Silva JMC: Quantiles for Counts. J Am Stat Assoc. 2005, 100: 1225-1237.CrossRef
39.
go back to reference Davies RJ, Ewings P, Welbourn R, Collins C, Kennedy R, Royle C: A prospective study to assess the implementation of a fast-track system to meet the two-week target for colorectal cancer in Somerset. Colorectal Dis. 2002, 4: 28-30. 10.1046/j.1463-1318.2002.00289.x.CrossRefPubMed Davies RJ, Ewings P, Welbourn R, Collins C, Kennedy R, Royle C: A prospective study to assess the implementation of a fast-track system to meet the two-week target for colorectal cancer in Somerset. Colorectal Dis. 2002, 4: 28-30. 10.1046/j.1463-1318.2002.00289.x.CrossRefPubMed
40.
go back to reference Dwivedi AK, Dwivedi SN, Deo S, Shukla R, Pandey A, Dwivedi DK: An Epidemiological study on delay in treatment initiation of cancer patients. Health. 2012, 4: 66-79. 10.4236/health.2012.42012.CrossRef Dwivedi AK, Dwivedi SN, Deo S, Shukla R, Pandey A, Dwivedi DK: An Epidemiological study on delay in treatment initiation of cancer patients. Health. 2012, 4: 66-79. 10.4236/health.2012.42012.CrossRef
41.
go back to reference Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F: Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011, 11: 284-10.1186/1472-6963-11-284.CrossRefPubMedPubMedCentral Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F: Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011, 11: 284-10.1186/1472-6963-11-284.CrossRefPubMedPubMedCentral
42.
go back to reference Murchie P, Campbell NC, Delaney EK, Dinant GJ, Hannaford PC, Johansson L, Lee AJ, Rollano P, Spigt M: Comparing diagnostic delay in cancer: a cross-sectional study in three European countries with primary care-led health care systems. Fam Pract. 2012, 29: 69-78. 10.1093/fampra/cmr044.CrossRefPubMed Murchie P, Campbell NC, Delaney EK, Dinant GJ, Hannaford PC, Johansson L, Lee AJ, Rollano P, Spigt M: Comparing diagnostic delay in cancer: a cross-sectional study in three European countries with primary care-led health care systems. Fam Pract. 2012, 29: 69-78. 10.1093/fampra/cmr044.CrossRefPubMed
Metadata
Title
Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study
Authors
Henry Jensen
Marie Louise Tørring
Frede Olesen
Jens Overgaard
Peter Vedsted
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-636

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine